Table.

TRPM2 and TRPM7 immunoreactivity histoscores (extensity × intensity) in all groups.

Groups	TRPM2	TRPM7
G1	0.23 (0.1–0.8)	0.66 (0.1–2.7)
G2	0.30 (0.1–0.6)	0.61 (0.1–1.2)
G3	0.32 (0.1–0.9)	0.65 (0.1–1.8)
G4	0.35 (0.1–1.2)	0.18 (0.0–0.5)a
G5	0.31 (0.1–0.6)	0.19 (0.0–0.5)a
G6	0.34 (0.1–0.8)	0.17 (0.0–0.4)a
P-value	<0.197	<0.001

a: When compared with G1, the TRPM7 immunoreactivity had significantly decreased in G4, G5, and G6 (P < 0.001). G1 = Proliferative endometrium; G2 = endometrial hyperplasia without atypia; G3 = endometrial hyperplasia with atypia; G4 = stage 1A, grade 1 endometrium adenocarcinoma; G5 = stage 1A, grade 2 endometrium adenocarcinoma; G6 = stage 1A, grade 3 endometrium adenocarcinoma.